• No results found

Clinical Decision Support

N/A
N/A
Protected

Academic year: 2021

Share "Clinical Decision Support"

Copied!
16
0
0

Loading.... (view fulltext now)

Full text

(1)
(2)

Clinical Decision Support Rule

Objective

Use clinical decision support to improve performance on high-priority

health conditions.

Measure

Measure 1:

Implement five clinical decision support interventions related to four or

more clinical quality measures at a relevant point in patient care for the

entire EHR reporting period. Absent four clinical quality measures related

to an EP’s scope of practice or patient population, the clinical decision

support interventions must be related to high-priority health conditions.

Measure 2:

The EP has enabled and implemented the functionality for drug-drug and

drug-allergy interaction checks for the entire EHR reporting period.

Exclusion

For the second measure, any EP who writes fewer than 100 medication

orders during the EHR reporting period.

(3)

Reminders 2.0

Upgrade to Reminders 2.0

Conversion to version 2.0 and 8+ years of

fixes/enhancements

Lots of new functionality on the RPMS side

Same look and feel in EHR but some enhanced dialog

functionality

Installing new reminders are a little different

Reminders installed on your RPMS when you load patch

will still work, but formatting may be a bit changed

You cannot install any v1.5 reminders once you have

loaded 2.0.

(4)

What Can I do Before Install?

Review your current reminders

Inactivate reminders not being used

Create a list of reminders currently

being used by your providers

Compare current reminders with

new version 2 reminders (2013

reminders) and update.

(5)

Compare Current Reminders with

Version 2

Reminder Definition List/Old

REMINDERS

Reminder Name

• Adult Immunization Due • Alcohol Screen

• ASBI(Blank) 10.2010

• Blank Reminder Exchange/RDL • Diab HBA1C

• Diabetic Foot Exam • Eric Foot Exam • Exchange Reminder • High Risk Flu

• IHS-Alcohol Screen • IHS-Asthma Plan • IHS-Asthma Prim Prov • IHS-Asthma Severity • IHS-Asthma Steroids • IHS-Blood Pressure • IHS-Colon Cancer • IHS-Depression Screen

List of NEW REMINDERS with the

CEHR 2014 Install

Reminder Name • IHS-Activity Screen 2013 • IHS-Alcohol Screen 2013 • IHS-Allergy 2013 • IHS-Anticoag Duration of TX 2013 • IHS-Anticoag INR Goal 2013

• IHS-Anticoag Therapy EHD Date 2013 • IHS-ASBI BNI 2013 (Dialog for TIU) • IHS-Asthma Control 2013

• IHS-Asthma Intake 2013 (dialog for TIU) • IHS-Asthma Prim Prov 2013

• IHS-Asthma Risk Exacerbation 2013 • IHS-Asthma Severity 2013 IHS-Asthma Steroid 2013 IHS-Blood Pressure 2013 • IHS-Chlamydia Screen 2013 • IHS-Colon Cancer 2013-2 5

(6)

Prioritize Reminders You Need to

Attest for MU2

“Implement five clinical decision support interventions

related to four or more clinical quality measures at a

relevant point in patient care for the entire EHR

reporting period.”

(7)

What Do I Need to Do

Right After Install?

Inactivate existing mammogram reminder

and install new mammogram reminders

(there are three).

If you have any Immunization reminders

deployed, you must install the new

Immunization reminders.

You do not have to move these into production

immediately, but you should replace your old

immunization reminders with the new ones fairly

soon.

(8)

What Do I Need to Do Right After

Install (cont.)

Check existing reminders to make sure

nothing is significantly changed in formatting.

The remaining reminders should work as

before.

Review new reminders and determine if any

need immediate updating.

(9)

Then What Do I Need to Do?

Update your reminders with the v2.0 set –

prioritize with reminders you need to attest

for MU2.

Review new functionality – reminders you

have wanted to build may now be possible.

Review the MU2_CDS Reminders and, if

needed, install additional reminders to

ensure five are deployed.

Set these at the

System Level.

(10)

Drug-Drug and Drug-Allergy check

“The EP, eligible hospital, or CAH has

enabled the functionality for drug-drug

and drug-allergy interaction checks for

the entire EHR reporting period.”

Enable drug-drug and drug-allergy

interaction at the

system level.

(11)

Order Checks Must be Set to Enabled

and Mandatory

These Order checks must be set to Enabled and

Mandatory:

ALLERGY-DRUG INTERACTION

ALLERGY-CONTRAST MEDIA INTERACTION

CRITICAL DRUG INTERACTION

DANGEROUS MEDS FOR PT > 64

ESTIMATED CREATININE CLEARANCE

GLUCOPHAGE-CONTRAST MEDIA

GLUCOPHAGE-LAB RESULTS

NO ALLERGY ASSESSMENT

RENAL FUNCTIONS OVER AGE 65

ALLERGY UNASSESSIBLE

(12)

How to Meet the Measure

For attestation, run the User Parameter Value

Report by Date for the reporting time period.

(13)

Parameter Report

The new parameter reports enable a site to

review the CDS tools that were enabled during

the reporting period.

Parameter Audit System Menu

MGPA Parameter Audit System Management ...

RPPA Parameter Audit Reports ...

(14)

Parameter Report (cont.)

RUPA User Parameter Value Report by Date

Select Parameter Audit Reports Option:

Rupa User Parameter Value Report by Date

Select one of the following:

1 User Defined Date Range 2 Quarter: January 1 - March 31 3 Quarter: April 1 - June 30 4 Quarter: July 1 - September 30 5 Quarter: October 1 - December 31

Select Report Period: (1-5): 5

Enter the Calendar Year for which report is to be run.

Use a 4 digit year, e.g. 2014.

Select Year: 2013 (2013) 2014 (2014)

Select one of the following:

IP Individual Provider

SEL Selected Providers (User Defined) TAX Provider Taxonomy List

Enter Selection: ip Individual Provider

Select a provider: NIESEN,MARY ANN MAN enter for Seven, Henry – display then run for User,Clerk

Parameter Selection

You may select one or more Parameters.

Press the <Enter> key without entering a name to conclude the selection process.

Enter "^" to abort the selection process.

Select a Parameter: ORQQPX COVER SHEET REMINDERS

Select a Parameter:

DEVICE: HOME// VT Right Margin: 80//

(15)

Parameter Report (more)

01/16/2014 Page: 1

ORQQPX COVER SHEET REMINDERS Parameter Report For provider: PRESCRIBERONE,ONE TEST

01/01/2014 - 03/31/2014*

*Auditing for this parameter was ENABLED on 01/16/2014

--- IHS-IMMUNIZATION FORECAST 2011 SYS 01/16/2014 - 01/16/2014 Lock

IHS-TOBACCO SCREEN 2013 SYS 01/16/2014 - 01/16/2014 Lock IHSMU2-ACE/ARB ALLERGY 2014 USR 01/16/2014 - 01/16/2014 Normal IHSMU2-ALLERGY 2014 USR 01/16/2014 - 01/16/2014 Normal IHSMU2-ANTICOAG INR GOAL 2013 USR 01/16/2014 - 01/16/2014 Normal IHSMU2-BP ELEVATED 2014 USR 01/16/2014 - 01/16/2014 Normal IHSMU2-DIAB ACE/ARB 2013 USR 01/16/2014 - 01/16/2014 Normal IHSMU2-DIAB BP CONTROL 2014 USR 01/16/2014 - 01/16/2014 Normal IHSMU2-DIAB HGBA1C CONTROL 2014 USR 01/16/2014 - 01/16/2014 Normal IHSMU2-HCT/HGB 2013 USR 01/16/2014 - 01/16/2014 Normal

(16)

Questions and Discussion

References

Related documents

The main objective of this study is to construct a theoretical insight from the pool of data using grounded theory approach to assess how the accountability is being carried out (the

In this document we derive some fundamental relationships between the Greeks of a barrier option under the Black-Scholes model.. A European-style option can be considered as a

3 For developing countries, we use a household income survey (‘HIS’ hereafter, e.g. the World Bank’s Living Standard Measurement Surveys) to calculate the quintile specific

A Typical Automation Application Suite for Machine Tool Builders Current engineering tools tend to focus on solving specific tasks at hand, such as configuring screens

These efforts include, but are not limited to, issuing and enforcing mandatory use policies for government wide and agency wide strategic sourcing solutions to

Our study used linked electronic healthcare data from primary and secondary care in Eng- land to calculate rates and costs of healthcare utilisation for patients with IBS before

The outcome of this study will be to ensure that patient- driven data inform decisions regarding surgery and precision rehabilitation by understanding the patient journey,

Thirty-two consecutive patients (19 female, 7 male; average age 69 years, range 49 – 90) with vertebral fractures of the thoracic spine of T8 and above were treated with KP